Zomedica Corp. Q3 FY2024 Earnings Call

Zomedica Corp. (ZOMDF)

Earnings Call FY2024 Q3 Call date: 2024-11-08 Concluded

Quarter scorecard

Revenue

$7.00M

+10.2% YoY

Diluted EPS

$-0.01

Gross margin

72.3%

+3.6 pp YoY

Net income

-$6.70M

Therapeutics $6.49M

+8.5%

Diagnostics $507,000

+38.1%